Uncategorized

NovaBay Pharmaceuticals to Present at Rodman & Renshaw 19th Annual Global Investment Conference

by Business Wire • 2017/09/05 • 0 Comments

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® lid and lash hygiene for the domestic eye care market, announces that Chief Financial Officer Jack McGovern is scheduled to present a corporate overview at the Rodman & Renshaw 19th Annual Global Investment Conference on Tuesday, September 12th, 2017, at 2:10 p.m. Eastern time (11:10 a.m. Pacific time). The conference is bein

Full Story →

← Global Ophthalmology Drugs Market to 2023 – Angiogenesis Inhibitors in wAMD Set to Retain High Market Share, While Expansive Pipeline for Glaucoma Leads the Research Landscape – Research and Markets

Kala Pharmaceuticals to Present at the 2017 Wells Fargo Healthcare Conference →

Post navigation